Vir Biotechnology, Inc. (VIR)
NASDAQ·Healthcare·Biotechnology
$9.08
+5.34%
Mkt Cap $1.39B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (18 analysts)
$21.14
Range $18.00 – $30.00
Implied Upside
+132.8%
Consensus $21.14 vs current $9.08
NASDAQ·Healthcare·Biotechnology
$9.08
+5.34%
Mkt Cap $1.39B
Buy
9
Hold
0
Sell
0
Price Target (18 analysts)
$21.14
Range $18.00 – $30.00
+132.8%
Consensus $21.14 vs current $9.08